97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05575505 (ClinicalTrials.gov) | February 2, 2023 | 8/10/2022 | Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. | Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. | Inflammatory Bowel Diseases | Drug: Pentoxifylline 400 MG | Tanta University | NULL | Recruiting | 18 Years | 75 Years | All | 44 | Phase 2 | Egypt |
2 | NCT05558761 (ClinicalTrials.gov) | October 10, 2022 | 25/9/2022 | Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis | Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colitis Treated With Mesalamine | Inflammatory Bowel Diseases | Drug: Pentoxifylline 400 MG | Tanta University | NULL | Recruiting | 18 Years | 75 Years | All | 50 | Phase 2 | Egypt |